antibiotic
therapy
cystic
fibrosis
increased
resistance
mucoid
pseudomonas
aeruginosa
carbenicillin
present
communication
report
effect
bacterial
mucus
activity
antibody
strain
p
aeruginosa
mucoid
variant
p
aeruginosa
obtained
non
mucoid
strain
pao
pat
selection
phenotypic
resistance
virulent
phage
e
resistant
carbenicillin
non
mucoid
parent
strain
mucoid
p
aeruginosa
strain
isolated
two
cf
patient
resistant
carbenicillin
non
mucoid
strain
isolated
sample
sputum
experiment
already
described
repeated
oxytetracycline
contrast
experience
carbenicillin
mucoid
strain
found
sensitive
non
mucoid
strain
prove
hypothesis
mucoid
strain
selected
vivo
carbenicillin
therapy
necessary
show
level
carbenicillin
cf
secretion
le
minimum
inhibitory
concentration
mucoid
strain
greater
non
mucoid
strain
investigating
additional
cf
isolates
conjunction
range
antibiotic
used
chemotherapy
cf
patient
